Paul Colbon

Paul Colbon is the current CEO and Director of Liverpool ChiroChem. Paul has over 25 years of experience in the medicinal chemistry industry, with a focus on the design and synthesis of innovative drug molecules for the treatment of cancer. Prior to their current role, Paul was the Medicinal Chemist at Redx Oncology from July 2012 to June 2014, where they were responsible for the design and synthesis of novel drug molecules for the treatment of cancer.

Some direct reports include Stuart Noble - CFO, Ilaria Proietti Silvestri - Head of Product Design, and Mark Jones - Head of PSL.